Episode 391
Brain tumours are the most common and most deadly form of solid tumours in children. But a brand new kind of immunotherapy has shown incredible promise, saving four terminally ill children.
By using a child’s own immune cells, this new treatment seems to work better than existing immunotherapies and causes fewer adverse side effects. Although it saved just 4 out of 33 participants, it’s still encouraging and researchers hope to continue trials.
Join James Woodford and Alice Klein to find out how this new therapy works, how researchers plan to improve it, why brain tumours are so common and difficult to treat and what the future of treatment looks like.
To read more about these stories, visit <a href="https://www.newscientist.com/">https://www.newscientist.com</a>/ Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

New Treatment Saves Children With Terminal Brain Cancer

The World, the Universe and Us

AI Chapters

AI Insights

Reviews